- Home
- TSBK vs TARA Comparison
TSBK vs TARA Comparison
Compare TSBK & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSBK | TARA |
|---|---|---|
| Founded | 1915 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.0M | 292.9M |
| IPO Year | 1997 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TSBK | TARA |
|---|---|---|
| Price | $41.00 | $4.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $24.40 |
| AVG Volume (30 Days) | 18.2K | ★ 705.9K |
| Earning Date | 04-28-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | 21.93 | ★ 38.25 |
| EPS | ★ 1.94 | N/A |
| Revenue | N/A | ★ $2,948,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.30 | $2.77 |
| 52 Week High | $43.55 | $7.82 |
Technical Indicators
Market Signals| Indicator | TSBK | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 49.19 | 45.21 |
| Support Level | $39.81 | $3.01 |
| Resistance Level | $42.40 | $5.53 |
| Average True Range (ATR) | 0.99 | 0.33 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 53.16 | 42.34 |
Price Performance
Historical ComparisonAbout TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company for Timberland Bank. The bank offers banking services including personal checking and savings accounts, debit cards, health savings accounts, online and mobile banking, online bill pay, 24-hour phone banking, and Zelle. Business services include business checking accounts, online banking, remote deposit, ACH transactions, Autobooks, and insured cash sweep services. The bank also provides lending services such as personal credit cards, home loans, home equity borrowing, construction loans, and SBA loans. In addition, it offers loans to real estate, including residential and commercial real estate, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.